CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
2.250
-0.040 (-1.75%)
At close: Oct 15, 2026, 4:00 PM EDT
2.280
+0.030 (1.33%)
After-hours: Oct 15, 2026, 7:52 PM EDT
CervoMed Market Cap
CervoMed has a market cap or net worth of $34.02 million as of October 15, 2026. It is the 33,097th most valuable company in the world and the 4,898th biggest in the United States. Its market cap has decreased by 55.27% in one year.
Market Cap
34.02M
Enterprise Value
9.08M
1-Year Change
-55.27%
Global Rank
Country Rank
#4,898 United States
Category
ChartMarket Cap Chart
Since August 17, 2023, CervoMed's market cap has decreased from $43.26M to $34.02M, a decrease of -21.37%. That is a compound annual growth rate of -7.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 34.02M | -53.46% |
| Dec 31, 2025 | 73.10M | 278.47% |
| Dec 31, 2024 | 19.31M | -55.39% |
| Dec 29, 2023 | 43.30M | 0.08% |
| Aug 17, 2023 | 43.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| eXoZymes | 37.13M |
| Filana Therapeutics | 36.75M |
| Lite Strategy | 36.34M |
| Edesa Biotech | 35.81M |
| NanoViricides | 35.22M |
| IRulya Therapeutics | 33.80M |
| Aligos Therapeutics | 33.03M |
| Actinium Pharmaceuticals | 33.01M |